Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Saulo Brito Silva"'
Autor:
Jamile Barboza de Oliveira, Saulo Brito Silva, Igor Lima Fernandes, Sabrina Setembre Batah, Andrea Jazel Rodriguez Herrera, Andrea de Cássia Vernier Antunes Cetlin, Alexandre Todorovic Fabro
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Despite treatment advances through immunotherapies, including anti-PD-1/PD-L1 therapies, the overall prognosis of non-small cell lung cancer (NSCLC) patients remains poor, underscoring the need for novel approaches that offer long-term clinical benef
Externí odkaz:
https://doaj.org/article/3e5b734dc4934f6a851ca14042c082ac
Autor:
Saulo Brito Silva, Rafael Balsini Barreto, Fernanda Cristina Gonçalves de Oliveira, Gabriela Schmidt Defende Martin, Ofelia Maria Yukie Takiguchi, Iasmin Alves Chirichela, Mário Henrique Furlanetto Miranda, Denize Bodnar, Luiz Augusto Alves Reis, Gabriel Clemente Brito Pereira, Isabela Lacerda Miranda, Bruno Rodriguez Pereira, Gustavo Viani Arruda, Fernanda Maris Peria
Publikováno v:
JCO Global Oncology, Vol , Iss 9 (2023)
PURPOSEPatients with brain metastases are often referred for brain radiotherapy (BrRT) when exclusive palliative management would be more appropriate. To assess the indication of BrRT during end-of-life (EOL) care and evaluate the characteristics of
Externí odkaz:
https://doaj.org/article/eaae6102b19345d995c3c249de39ef7b
Autor:
Saulo Brito Silva, Carlos Wagner S. Wanderley, José Flavio Gomes Marin, Mariana Petaccia de Macedo, Ellen Caroline Toledo do Nascimento, Fernanda Frozoni Antonacio, Caroline Sales Figueiredo, Mateus Trinconi Cunha, Fernando Q. Cunha, Gilberto de Castro Junior
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 14 (2022)
Background: A significant proportion of patients with non-small-cell lung cancer (NSCLC) do not respond to immune checkpoint inhibitors (ICIs). Since metabolic reprogramming with increased glycolysis is a hallmark of cancer and is involved in immune
Externí odkaz:
https://doaj.org/article/21b9dc841f9f476aaeccc1bd673df974
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Cancer cells harbor genomic instability due to accumulated DNA damage, one of the cancer hallmarks. At least five major DNA Damage Repair (DDR) pathways are recognized to repair DNA damages during different stages of the cell cycle, comprehending bas
Externí odkaz:
https://doaj.org/article/ef68faf82c744d3f919a49f658ae0b09
Autor:
Saulo Brito Silva, Carlos Wagner S. Wanderley, José Flavio Gomes Marin, Mariana Petaccia de Macedo, Ellen Caroline Toledo do Nascimento, Fernanda Frozoni Antonacio, Caroline Sales Figueiredo, Mateus Trinconi Cunha, Fernando Q. Cunha, Gilberto de Castro Junior
Publikováno v:
Therapeutic Advances in Medical Oncology. 14:175883592211383
Background: A significant proportion of patients with non-small-cell lung cancer (NSCLC) do not respond to immune checkpoint inhibitors (ICIs). Since metabolic reprogramming with increased glycolysis is a hallmark of cancer and is involved in immune
Autor:
José Roberto Filassi, Adriana Reis Brandao Matutino, Kennya Medeiros Lopes de Barros Lima, Saulo Brito Silva, Julianne Maria da Silva Lima, Pedro Antonio Hermida de Viveiros, Gustavo Nader Marta, Manoel Carlos L. A. Souza, Thiago Brasileiro de Freitas, José Roberto Morales Piato, Allan Andresson Lima Pereira, Heloisa de Andrade Carvalho, Max S. Mano, Renata Gondim Meira Velame de Azevedo
Publikováno v:
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Universidade de São Paulo (USP)
instacron:USP
and Purpose: Post-operative radiation therapy (PORT) is usually indicated for patients with breast cancer (BC) after neoadjuvant chemotherapy (NAC) and surgery. However, the optimal timing to initiation of PORT is currently unknown.We retrospectively
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22f48927a2e8cc2e0cee14e73cf4c5c7
Autor:
Thiago Brasileiro de Freitas, Heloisa de Andrade Carvalho, Max S. Mano, José Roberto Filassi, Kennya Medeiros Lopes de Barros Lima, Saulo Brito Silva, Gustavo Nader Marta, Allan Andresson Lima Pereira
Publikováno v:
Mastology. 28:57-57
Autor:
Max S. Mano, Maria Fernanda B. Vicentini, Adriana Reis Brandao Matutino, Rudinei Diogo Marques Linck, Debora de Melo Gagliato, Aumilto Augusto Silva, Saulo Brito Silva, Marcelo Felizola, Julianne Maria da Silva Lima, Paulo M. Hoff
Publikováno v:
Journal of Clinical Oncology. 34:e12575-e12575
e12575Background: Metaplastic breast cancer (MBC) is a rare breast cancer (BC) subtype, representing less than 1% of all BC cases. Because of its rarity, it has been traditionally treated similarly to invasive ductal carcinoma (IDC). Nevertheless, co